Two Sigma Advisers LP Has $2.29 Million Stock Position in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Two Sigma Advisers LP raised its stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 693.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 35,700 shares of the company's stock after acquiring an additional 31,200 shares during the period. Two Sigma Advisers LP's holdings in Ryan Specialty were worth $2,291,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in RYAN. Barclays PLC raised its holdings in Ryan Specialty by 1.1% in the 3rd quarter. Barclays PLC now owns 1,641,743 shares of the company's stock valued at $108,994,000 after acquiring an additional 17,267 shares in the last quarter. SG Americas Securities LLC raised its holdings in Ryan Specialty by 94.2% in the 4th quarter. SG Americas Securities LLC now owns 3,253 shares of the company's stock valued at $209,000 after acquiring an additional 1,578 shares in the last quarter. Janney Montgomery Scott LLC increased its stake in shares of Ryan Specialty by 4.9% in the 4th quarter. Janney Montgomery Scott LLC now owns 17,825 shares of the company's stock valued at $1,144,000 after purchasing an additional 831 shares during the last quarter. Exchange Traded Concepts LLC increased its stake in shares of Ryan Specialty by 2.6% in the 4th quarter. Exchange Traded Concepts LLC now owns 11,760 shares of the company's stock valued at $755,000 after purchasing an additional 295 shares during the last quarter. Finally, KBC Group NV increased its stake in shares of Ryan Specialty by 1,803.6% in the 4th quarter. KBC Group NV now owns 46,181 shares of the company's stock valued at $2,963,000 after purchasing an additional 43,755 shares during the last quarter. 84.82% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on RYAN shares. Wells Fargo & Company decreased their price target on Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating on the stock in a research note on Thursday, April 10th. Barclays decreased their price target on Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating on the stock in a research note on Friday, April 11th. The Goldman Sachs Group upgraded Ryan Specialty from a "neutral" rating to a "buy" rating and lifted their price target for the company from $74.00 to $81.00 in a research note on Tuesday, May 13th. Morgan Stanley lifted their price target on Ryan Specialty from $78.00 to $80.00 and gave the company an "overweight" rating in a research note on Monday, May 19th. Finally, Royal Bank of Canada decreased their price target on Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating on the stock in a research note on Friday, February 21st. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and eight have given a buy rating to the company. According to data from MarketBeat.com, Ryan Specialty presently has an average rating of "Moderate Buy" and an average target price of $75.58.

Insiders Place Their Bets

In other Ryan Specialty news, EVP Brendan Martin Mulshine sold 30,000 shares of Ryan Specialty stock in a transaction dated Friday, March 14th. The stock was sold at an average price of $69.30, for a total transaction of $2,079,000.00. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Company insiders own 52.21% of the company's stock.

Ryan Specialty Price Performance

RYAN stock traded up $1.67 during midday trading on Friday, reaching $71.61. 704,225 shares of the stock were exchanged, compared to its average volume of 987,727. The stock has a market capitalization of $18.79 billion, a PE ratio of 103.78, a P/E/G ratio of 1.19 and a beta of 0.68. Ryan Specialty Holdings, Inc. has a 52 week low of $52.34 and a 52 week high of $77.16. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. The company has a fifty day moving average price of $69.90 and a 200 day moving average price of $68.73.

Ryan Specialty (NYSE:RYAN - Get Free Report) last announced its earnings results on Thursday, May 1st. The company reported $0.39 EPS for the quarter, hitting the consensus estimate of $0.39. The firm had revenue of $690.17 million for the quarter, compared to the consensus estimate of $680.80 million. Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. The business's quarterly revenue was up 25.0% compared to the same quarter last year. During the same period in the previous year, the business earned $0.35 EPS. As a group, analysts expect that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current fiscal year.

Ryan Specialty Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, May 27th. Shareholders of record on Tuesday, May 13th were issued a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 0.67%. The ex-dividend date of this dividend was Tuesday, May 13th. Ryan Specialty's payout ratio is presently 141.18%.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.